Isomer-specific binding affinity of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) to serum proteins

Environmental Science and Technology

Volumn 49, Issue 9, 2015, Pages 5722-5731

  Beesoon, Sanjay ^a   Martin, Jonathan W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BODY FLUIDS; DISSOCIATION; MIXTURES; PLANTS (BOTANY); PROTEINS;

DISSOCIATION CONSTANT; HUMAN SERUM ALBUMINS; MOLECULAR MECHANISM; PERFLUOROOCTANE SULFONATES; PERFLUOROOCTANOATE; RELATIVE BINDING AFFINITY; TRANSPLACENTAL TRANSFERS; ULTRAFILTRATION DEVICES;

ISOMERS;

HUMAN SERUM ALBUMIN; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PLASMA PROTEIN; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; SERUM ALBUMIN;

ANIMAL; CHEMICAL BINDING; MOLECULAR ANALYSIS; PROTEIN; SERUM; ULTRAFILTRATION;

ARTICLE; BINDING AFFINITY; BLOOD PLACENTA BARRIER; DISSOCIATION CONSTANT; DRUG DISPOSITION; FEMALE; HALF LIFE TIME; HUMAN; ISOMER; KIDNEY CLEARANCE; PLACENTAL TRANSFER; PROTEIN BLOOD LEVEL; ULTRAFILTRATION; ANIMAL; BINDING SITE; BOVINE; CHEMISTRY; ISOMERISM; KINETICS; METABOLISM; SERUM;

ANIMALIA;

ALKANESULFONIC ACIDS; ANIMALS; BINDING SITES; CAPRYLATES; CATTLE; FLUOROCARBONS; HUMANS; ISOMERISM; KINETICS; SERUM; SERUM ALBUMIN;

EID: 84928905377     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es505399w     Document Type: Article

References (71)

1. Fluorochemical use distribution and release inventory; 3M Company: USA, 1999.
2. Washburn, S. T.; Bingman, T. S.; Braithwaite, S. K.; Buck, R. C.; Buxton, L. W.; Clewell, H. J.; Haroun, L. A.; Kester, J. E.; Rickard, R. W.; Shipp, A. M. Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles Environ. Sci. Technol. 2005, 39, 3904-3910
3. Kannan, K.; Corsolini, S.; Falandysz, J.; Fillmann, G.; Kumar, K. S.; Loganathan, B. G.; Mohd, M. A.; Olivero, J.; Van Wouwe, N.; Yang, J. H.; Aldous, K. M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries Environ. Sci. Technol. 2004, 38, 4489-4495
4. Mariussen, E. Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance Arch. Toxicol. 2012, 86, 1349-1367
5. Lau, C.; Butenhoff, J. L.; Rogers, J. M. The developmental toxicity of perfluoroalkyl acids and their derivatives Toxicol. Appl. Pharmacol. 2004, 198, 231-241
6. Lau, C.; Anitole, K.; Hodes, C.; Lai, D.; Pfahles-Hutchens, A.; Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicol. Sci. 2007, 99, 366-394
7. Knox, S. S.; Jackson, T.; Javins, B.; Frisbee, S. J.; Shankar, A.; Ducatman, A. M. Implications of early menopause in women exposed to perfluorocarbons J. Clin. Endocrinol. Metab. 2011, 96, 1747-1753
8. White, S. S.; Fenton, S. E.; Hines, E. P. Endocrine disrupting properties of perfluorooctanoic acid J. Steroid Biochem. Mol. Biol. 2011, 127, 16-26
9. Nelson, J. W.; Hatch, E. E.; Webster, T. F. Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General US Population Environ. Health Perspect. 2010, 118, 197-202
10. Frisbee, S. J.; Shankar, A.; Knox, S. S.; Steenland, K.; Savitz, D. A.; Fletcher, T.; Ducatman, A. M. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project Arch. Pediatr. Adolesc. Med. 2010, 164, 860-869
11. Eriksen, K. T.; Raaschou-Nielsen, O.; McLaughlin, J. K.; Lipworth, L.; Tjonneland, A.; Overvad, K.; Sorensen, M. Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population PLoS One 2013, 8, 2
12. Shankar, A.; Xiao, J.; Ducatman, A. Perfluorooctanoic Acid and Cardiovascular Disease in US Adults Arch Int. Med. 2012, 172, 1397-1403
13. Okada, E.; Sasaki, S.; Saijo, Y.; Washino, N.; Miyashita, C.; Kobayashi, S.; Konishi, K.; Ito, Y. M.; Ito, R.; Nakata, A.; Iwasaki, Y.; Saito, K.; Nakazawa, H.; Kishi, R. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants Environ. Res. 2012, 112, 118-125
14. Grandjean, P.; Andersen, E. W.; Budtz-Jørgensen, E.; Nielsen, F.; Mølbak, K.; Weihe, P.; Heilmann, C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds JAMA, J. Am. Med. Assoc. 2012, 307 (4) 391-7
15. Sakr, C. J.; Leonard, R. C.; Kreckmann, K. H.; Slade, M. D.; Cullen, M. R. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate J. Occup. Environ. Med. 2007, 49 (8) 872-879
16. Steenland, K.; Tinker, S.; Shankar, A.; Ducatman, A. Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Uric Acid among Adults with Elevated Community Exposure to PFOA Environ. Health Perspect. 2010, 118, 229-233
17. Geiger, S. D.; Xiao, J.; Shankar, A. Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in Children Am. J. Epidemiol. 2013, 177, 1255-1262
18. Olsen, G. W.; Zobel, L. R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers Int. Arch. Occ. Env. Hea. 2007, 81, 231-246
19. Melzer, D.; Rice, N.; Depledge, M. H.; Henley, W. E.; Galloway, T. S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey Environ. Health Perspect. 2010, 118, 686-692
20. Lopez-Espinosa, M. J.; Fletcher, T.; Armstrong, B.; Genser, B.; Dhatariya, K.; Mondal, D.; Ducatman, A.; Leonardi, G. Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty among Children Living near a Chemical Plant Environ. Sci. Technol. 2011, 45, 8160-8166
21. Joensen, U. N.; Veyrand, B.; Antignac, J.-P.; Jensen, M. B.; Petersen, J. H.; Marchand, P.; Skakkebaek, N. E.; Andersson, A.-M.; Le Bizec, B.; Jorgensen, N. PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men Hum. Reprod. 2013, 28, 599-608
22. Hoffman, K.; Webster, T. F.; Weisskopf, M. G.; Weinberg, J.; Vieira, V. M. Exposure to Polyfluoroalkyl Chemicals and Attention Deficit/Hyperactivity Disorder in US Children 12-15 Years of Age Environ. Health Perspect. 2010, 118, 1762-1767
23. Stein, C. R.; Savitz, D. A. Serum Perfluorinated Compound Concentration and Attention Deficit/Hyperactivity Disorder in Children 5-18 Years of Age Environ. Health Perspect. 2011, 119, 1466-1471
24. Gump, B. B.; Wu, Q.; Dumas, A. K.; Kannan, K. Perfluorochemical (PFC) Exposure in Children: Associations with Impaired Response Inhibition Environ. Sci. Technol. 2011, 8151-8159
25. Kvist, L.; Giwercman, Y. L.; Jonsson, B. A. G.; Lindh, C. H.; Bonde, J. P.; Toft, G.; Strucinski, P.; Pedersen, H. S.; Zvyezday, V.; Giwercman, A. Serum levels of perfluorinated compounds and sperm Y:X chromosome ratio in two European populations and in Inuit from Greenland Reprod. Toxicol. 2012, 34, 644-650
26. Vestergaard, S.; Nielsen, F.; Andersson, A.-M.; Hjollund, N. H.; Grandjean, P.; Andersen, H. R.; Jensen, T. K. Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive Hum. Reprod. 2012, 27, 873-880
27. Whitworth, K. W.; Haug, L. S.; Baird, D. D.; Becher, G.; Hoppin, J. A.; Skjaerven, R.; Thomsen, C.; Eggesbo, M.; Travlos, G.; Wilson, R.; Longnecker, M. P. Perfluorinated Compounds and Subfecundity in Pregnant Women Epidemiology 2012, 23, 257-263
28. Fei, C. Y.; McLaughlin, J. K.; Lipworth, L.; Olsen, J. Maternal levels of perfluorinated chemicals and subfecundity Hum. Reprod. 2009, 24, 1200-1205
29. Inoue, K.; Okada, F.; Ito, R.; Kato, S.; Sasaki, S.; Nakajima, S.; Uno, A.; Saijo, Y.; Sata, F.; Yoshimura, Y.; Kishi, R.; Nakazawa, H. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy Environ. Health Perspect. 2004, 112, 1204-1207
30. Grice, M. M.; Alexander, B. H.; Hoffbeck, R.; Kampa, D. M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers J. Occup. Environ. Med. 2007, 49, 722-729
31. Apelberg, B. J.; Witter, F. R.; Herbstman, J. B.; Calafat, A. M.; Halden, R. U.; Needham, L. L.; Goldman, L. R. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth Environ. Health Perspect. 2007, 115, 1670-1676
32. Stein, C. R.; Savitz, D. A.; Dougan, M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome Am. J. Epidemiol. 2009, 170, 837-846
33. 3M Phase-Out Plan for POSF-Based Products; U.S. EPA Docket ID OPPT-2002-0043.; U. S. EPA: 2000.
34. Hansen, K. J.; Clemen, L. A.; Ellefson, M. E.; Johnson, H. O. Compound-specific, quantitative characterization of organic: Fluorochemicals in biological matrices Environ. Sci. Technol. 2001, 35, 766-770
35. Giesy, J. P.; Kannan, K. Global distribution of perfluorooctane sulfonate in wildlife Environ. Sci. Technol. 2001, 35, 1339-42
36. Reagen, W. K.; Lindstrom, K. R.; Jacoby, C. B.; Purcell, R. G.; Kestner, T. A.; Payfer, R. M.; Miller, J. W. Environmental characterization of 3M electrochemical fluorination derived perfluorooctanoate and perfluorooctanesulfonate. Society of Environmental Toxicology and Chemistry 28th North American meeting, Milwaukee, WI, USA. Nov. 11-15, 2007.
37. Loveless, S. E.; Finlay, C.; Everds, N. E.; Frame, S. R.; Gillies, P. J.; O'Connor, J. C.; Powley, C. R.; Kennedy, G. L. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO) Toxicology 2006, 220, 203-217
38. O'Brien, J. M.; Austin, A. J.; Williams, A.; Yauk, C. L.; Crump, D.; Kennedy, S. W. Technical-grade perfluorooctane sulfonate alters the expression of more transcripts in cultured chicken embryonic hepatocytes than linear perfluorooctane sulfonate Environ. Toxicol. Chem. 2011, 30, 2846-2859
39. Sharpe, R. L.; Benskin, J. P.; Laarman, A. H.; Macleod, S. L.; Martin, J. W.; Wong, C. S.; Goss, G. G. Perfluorooctane sulfonate toxicity, isomer-specific accumulation, and maternal transfer in zebrafish (Danio rerio) and rainbow trout (Oncorhynchus mykiss) Environ. Toxicol. Chem. 2010, 29, 1957-1966
40. O'Brien, J. M.; Kennedy, S. W.; Chu, S.; Letcher, R. J. Isomer-specific accumulation of perfluorooctane sulfonate in the liver of chicken embryos exposed in ovo to a technical mixture Environ. Toxicol. Chem. 2011, 30, 226-231
41. Benskin, J. P.; De Silva, A. O.; Martin, L. J.; Arsenault, G.; McCrindle, R.; Riddell, N.; Mabury, S. A.; Martin, J. W. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose Environ. Toxicol. Chem. 2009, 28, 542-554
42. De Silva, A. O.; Benskin, J. P.; Martin, L. J.; Arsenault, G.; McCrindle, R.; Riddell, N.; Martin, J. W.; Mabury, S. A. Disposition of Perfluorinated Acid Isomers in Sprague-Dawley Rats; Part 2: Subchronic Dose Environ. Toxicol. Chem. 2009, 28, 555-567
43. Greaves, A. K.; Letcher, R. J. Linear and branched perfluorooctane sulfonate (PFOS) isomer patterns differ among several tissues and blood of polar bears Chemosphere 2013, 93, 574-580
44. Zhang, Y.; Beesoon, S.; Zhu, L.; Martin, J. W. Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life Environ. Sci. Technol. 2013, 47, 10619-10627
45. Beesoon, S.; Webster, G. M.; Shoeib, M.; Harner, T.; Benskin, J. P.; Martin, J. W. Isomer Profiles of Perfluorochemicals in Matched Maternal, Cord, and House Dust Samples: Manufacturing Sources and Transplacental Transfer Environ. Health Perspect. 2011, 119, 1659-1664
46. Kärrman, A.; Järnberg, U.; van Bavel, B.; Lindström, G. Isomer pattern of PFOS in human blood. Fluoros International Symposium Abstract Book; Department of Chemistry, University of Toronto: Toronto, 2005.
47. Martin, J. W.; Asher, B. J.; Beesoon, S.; Benskin, J. P.; Ross, M. S. PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure? J. Environ. Monit. 2010, 12, 1979-2004
48. Benskin, J. P.; Holt, A.; Martin, J. W. Isomer-Specific Biotransformation Rates of a Perfluorooctane Sulfonate (PFOS)-Precursor by Cytochrome P450 Isozymes and Human Liver Microsomes Environ. Sci. Technol. 2009, 43, 8566-8572
49. Gutzkow, K. B.; Haug, L. S.; Thomsen, C.; Sabaredzovic, A.; Becher, G.; Brunborg, G. Placental transfer of perfluorinated compounds is selective-A Norwegian Mother and Child sub-cohort study Int. J. Hyg. Environ. Heal 2012, 216-219
50. Hanssen, L.; Rollin, H.; Odland, J. O.; Moe, M. K.; Sandanger, T. M. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study J. Environ. Monit. 2010, 12, 1355-1361
51. Plonait, S. L.; Heinz, N., Physico-chemical and structural properties regulating placental drug transfer. In Fetal and Neonatal Physiology, Fourth ed.; Judith, F., Ed.; Elselvier Saunders: Philadelphia, PA, 2011; pp 231-245.
52. Benskin, J. P.; Bataineh, M.; Martin, J. W. Simultaneous characterization of perfluoroalkyl carboxylate, sulfonate, and sulfonamide isomers by liquid chromatography-tandem mass spectrometry Anal. Chem. 2007, 79, 6455-6464
53. Sastry, R. Techniques to study human placental transport Adv. Drug Delivery Rev. 1999, 38, 17-39
54. Sastry, R. Placental Toxicology; CRC Press: Boca Raton, FL, 1995.
55. Jones, P. D.; Hu, W. Y.; De Coen, W.; Newsted, J. L.; Giesy, J. P. Binding of perfluorinated fatty acids to serum proteins Environ. Toxicol. Chem. 2003, 22, 2639-2649
56. Zhang, X.; Chen, L.; Fei, X. C.; Ma, Y. S.; Gao, H. W., Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals. BMC Mol. Biol. 2009, 10.
57. Han, X.; Snow, T. A.; Kemper, R. A.; Jepson, G. W. Binding of perfluorooctanoic acid to rat and human plasma proteins Chem. Res. Toxicol. 2003, 16, 775-781
58. Bischel, H. N.; MacManus-Spencer, L. A.; Zhang, C.; Luthy, R. G. Strong associations of short-chain perfluoroalkyl acids with serum albumin and investigation of binding mechanisms Environ. Toxicol. Chem. 2011, 30, 2423-2430
59. Bischel, H.; MacManus-Spencer, L.; Luthy, R. Noncovalent Interactions of Long-Chain Perfluoroalkyl Acids with Serum Albumin Environ. Sci. Technol. 2010, 32-44
60. Ng, C. A.; Hungerbuhler, K. Bioconcentration of Perfluorinated Alkyl Acids: How Important Is Specific Binding? Environ. Sci. Technol. 2013, 47, 7214-7223
61. Clarkson, J. R.; Cui, Z. F.; Darton, R. C. Protein Denaturation in Foam J. Colloid Interface Sci. 1999, 215, 333-338
62. Dow, N. Determination of compound binding to plasma proteins. Current Protocols in Pharmacology; Wiley: New York, 2006; Chapter 7, Unit 7.5.
63. Gu, J.; Soldin, O. P.; Soldin, S. J. Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry Clin. Biochem. 2007, 40, 1386-1391
64. Jensen, B. P.; Chin, P. K.; Begg, E. J. Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltration and LC-MS/MS Anal. Bioanal. Chem. 2011, 401, 2187-2193
65. Salvalaglio, M.; Muscionico, I.; Cavallotti, C. Determination of Energies and Sites of Binding of PFOA and PFOS to Human Serum Albumin J. Phys. Chem. B 2010, 114, 14860-14874
66. Luo, Z. P.; Shi, X. L.; Hu, Q.; Zhao, B.; Huang, M. D. Structural Evidence of Perfluorooctane Sulfonate Transport by Human Serum Albumin Chem. Res. Toxicol. 2012, 25, 990-992
67. Chen, Y. M.; Guo, L. H. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin Arch. Toxicol. 2009, 83, 255-261
68. Wu, L. L.; Gao, H. W.; Gao, N. Y.; Chen, F. F.; Chen, L. Interaction of perfluorooctanoic acid with human serum albumin BMC Struct. Biol. 2009, 9, 31 10.1186/1472-6807-9-31
69. Hebert, P. C.; MacManus-Spencer, L. A. Development of a Fluorescence Model for the Binding of Medium- to Long-Chain Perfluoroalkyl Acids to Human Serum Albumin Through a Mechanistic Evaluation of Spectroscopic Evidence Anal. Chem. 2010, 82, 6463-6471
70. D'eon, J. C.; Simpson, A. J.; Kumar, R.; Baer, A. J.; Mabury, S. A. Determining the molecular interactions of perfluorinated carboxylic acids within human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy Environ. Toxicol. Chem. 2010, 29, 1678-1688
71. Bhattacharya, A. A.; Grüne, T.; Curry, S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303: 721-732.